October 2014 in “Archives of disease in childhood” This study found that parents of children with cancer experienced significant somatic health issues during and after their child's treatment, with increased complications reported after treatment.
November 2013 in “Dalhousie Medical Journal” This review discusses the epidemiology and cutaneous manifestations of lupus erythematosus, highlighting comparable incidence rates between cutaneous and systemic forms, but reports no new findings.
September 2010 in “Institutional Repositories DataBase (IRDB)” Sorafenib can cause a temporary skin condition that goes away after stopping the drug.
March 2010 in “Anti-inflammatory & anti-allergy agents in medicinal chemistry” This review details the adverse effects and drug interactions of biologic agents used in rheumatoid disease treatment, highlighting their significant side effect profile without reporting new clinical findings.
This article reviews potential drug and herbal interactions with warfarin that may increase bleeding risk, and reports no new clinical results.
September 2005 in “Clinics in Plastic Surgery” This article discusses multiple aspects of complex regional pain syndrome, including its diagnosis, pathogenesis, and treatment, but reports no new scientific findings.
September 1993 in “Archives of Disease in Childhood” This article discusses the importance of considering biotin deficiency in diagnosing neurological, dermatological, or respiratory illnesses linked to hair loss, and reports no new research results.
August 1984 in “Australasian Journal of Dermatology” This review discusses two books on dermatology and clinical medicine but provides no experimental findings or new clinical results.
February 2021 in “Медико-фармацевтический журнал "Пульс"” This study explored the roles of β-catenin and sclerostin levels in patients with androgenic and alopecia areata, analyzing their potential involvement in the hair follicle morphogenesis and Wnt signaling pathway.
November 2020 in “Acta Scientific Women's Health” In this study of women treated for dermatological conditions in West Midlands, England, low vitamin D levels were significantly linked to hair loss, especially in women aged 35-45, suggesting vitamin D's potential role in prevention and treatment of hair loss in this group.
April 2014 in “The FASEB Journal” This study examined 12 women with androgenetic alopecia and found that many had other symptoms linked to hyperandrogenism, suggesting the importance of further hormone level investigations.
September 1997 in “Journal of The European Academy of Dermatology and Venereology” Alopecia linked to higher anxiety and personality disorders.
41 citations
,
September 1991 in “Medical hypotheses” This article reviews the potential role of prolactin as a neuroendocrine modulator in skin biology and pathology, discussing its relevance for conditions such as psoriasis and hair growth, but reports no new clinical findings.
3 citations
,
November 2016 in “The journal of investigative dermatology/Journal of investigative dermatology” This article discusses the evolving landscape of dermatology, highlighting challenges pharmaceutical companies face with novel drug development, while smaller dermatology-focused companies lead in innovation; it reports no new results.
2 citations
,
May 2025 in “Aesthetic Surgery Journal” This review highlights that hair transplantation can be a reconstructive treatment for various types of alopecia, including secondary scarring, congenital, and select primary scarring and nonscarring dermatological alopecias.
This study identified ten key magistral dermatological formulations, such as personalized trichological preparations and Kligman’s formula, which fill critical gaps unmet by standardized products, particularly in cases like pediatric scabies or autoimmune mucosal diseases, illustrating the role of compounding in precision medicine.
February 2026 in “International Journal of Homoeopathic Sciences” In this case report at Dr Batra’s Homeopathy Clinic, individualized classical homeopathy over 54 months led to sustained hair regrowth and disease stabilization in a patient with chronic alopecia areata, illustrating the potential benefits of holistic treatment approaches in managing this condition.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” In this product description, it is reported that SwaLife Onion Shampoo combines Ayurvedic and dermatological principles to nourish the scalp, strengthen hair roots, and restore shine by using modern extraction techniques for onion extract along with other botanicals.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This source describes the SwaLife Onion Shampoo as an Ayurvedic-dermatological formulation intended to nourish the scalp, strengthen hair roots, and enhance hair thickness and shine through a blend of onion extract and botanicals, without reporting specific study results.
April 2025 in “International Journal of Research in Dermatology” This study investigated cutaneous manifestations in thyroid disorder patients, finding that hypothyroid patients commonly experienced dry skin (67.83%) while warm skin (93.3%) and increased sweating prevailed in hyperthyroid patients, with urticaria being the most common autoimmune association among both groups.
January 2024 in “Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica/Revista de la Asociacion Colombiana de Dermatologia y Cirugia Dermatologica” This case report highlights the successful treatment of alopecia areata universalis with Baricitinib, suggesting potential long-term effectiveness of janus kinase inhibitors for this autoimmune hair loss condition.
February 2021 in “PDEAS International Journal of Research in Ayurved and Allied Sciences” This review discusses the historical and traditional perspectives of Ayurvedic hair science, highlighting its underrepresentation in modern clinical research and the potential for integrative dermatology approaches, but it reports no new findings.
40 citations
,
July 2018 in “European Journal of Pharmaceutical Sciences” This study found that melatonin-loaded vitamin C-based nanovesicles improved hair thickness, density, and reduced hair loss in patients with androgenic alopecia more effectively than melatonin solution.
12 citations
,
March 2022 in “Dermatologic Therapy” This report presents a case of a patient developing new multiple sclerosis while using tofacitinib for alopecia areata, noting no new comprehensive research findings.
8 citations
,
August 2020 in “Clinical and Experimental Dermatology” In this review, spironolactone is highlighted for its emerging use in dermatology, particularly for treating androgen-mediated conditions like acne and hirsutism in susceptible females, though it requires careful monitoring for potential adverse effects.
This study reviewed the use of self-supervised Auto ML models for detecting alopecia areata, finding significant advancements in automated diagnosis but also challenges such as model explainability and data bias, which may guide future AI-driven dermatological diagnostics.
1 citations
,
September 2024 in “Dermatological Reviews” In this systematic review, significant improvements in clinical severity, patient-reported outcomes, and quality of life were reported for dupilumab compared to placebo in patients with moderate-to-severe atopic dermatitis, prurigo nodularis, and alopecia areata, supporting its efficacy and safety for these dermatological conditions.
2 citations
,
December 2011 in “Annales de Dermatologie et de Vénéréologie” 2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.
June 2026 in “Current Cardiology Reviews” This review highlights the significant relationship between dermatological disorders and cardiovascular risk, suggesting that reducing systemic inflammation may help mitigate cardiovascular complications in affected patients.
January 2024 in “JEADV Clinical Practice” This study from the Danish Skin Cohort found that patients with alopecia areata, followed by those with hidradenitis suppurativa, were willing to spend the most daily time on treatment, reflecting possible unmet needs, and that this willingness correlated with disease severity across different dermatological conditions.